LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation
2017 · Cancer Letters · 50 citations
https://doi.org/10.1016/j.canlet.2017.11.035
S
Shuyu Hao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
170
Papers
3.0K
Citations
30
h-index
89
i10-index
Shuyu Hao is an academic researcher from Capital University. The author has contributed to research in topics: Meningioma and schwannoma management & Glioma Diagnosis and Treatment & Neurofibromatosis and Schwannoma Cases. The author has an h-index of 30, co-authored 145 publications.
ORCID: 0000-0002-4224-9424Papers by this author
worksCollision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region
2013 · World Journal of Surgical Oncology · 46 citations
https://doi.org/10.1186/1477-7819-11-178
Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review
2015 · World Journal of Surgical Oncology · 24 citations
https://doi.org/10.1186/s12957-015-0558-x
Idiopathic and radiation-induced myxofibrosarcoma in the head and neck—case report and literature review
2021 · Chinese Neurosurgical Journal · 6 citations
https://doi.org/10.1186/s41016-021-00267-9
The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma
2025 · JCI Insight · 5 citations
https://doi.org/10.1172/jci.insight.173700
Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG
2025 · Journal of Experimental & Clinical Cancer Research · 2 citations
https://doi.org/10.1186/s13046-025-03390-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat